Population
Patients with familial combined hyperlipidaemia
Design
Review
Authors
Loading...
Metabolic pathway advances in familial combined hyperlipidaemia should not yet alter management; leaves open targeted therapy trials.
This review summarizes recent advances in the understanding of metabolic pathways involved in familial combined hyperlipidaemia, a common inherited condition linked to premature myocardial infarction.
Graaf et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: